- Integration
- The FDA package describes processing of previously acquired CT DICOM studies; exact local routing, archive, and output behavior remain unverified.
FDA source Exact FDA submission Checked 2026-09-04
This is the interface boundary described in the exact FDA package; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.
- Deployment and data flow
- Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04
The exact public FDA decision material does not establish the complete deployment topology, hosting responsibility, availability, upgrade path, or service contract.
- Security and privacy
- Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
- Training and support
- Only radiologists, physicians, and other trained cardiovascular imaging professionals should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
FDA source Exact FDA submission Checked 2026-09-04
- Monitoring and change control
- Monitor K183268 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The FDA validation scope is adult CT DICOM data with specified scanner and reconstruction conditions; do not generalize it to unsupported scanners, protocols, populations, or anatomy.
FDA source Exact FDA submission Checked 2026-09-04
Monitoring guidance is buyer-facing implementation guidance derived from the exact cleared scope; it is not a claim that the FDA package provides a live monitoring service.
Release and scope verification
Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K183268 before acceptance.
exact submission · checked 2026-09-04 Later product-family features are not evidence that this cleared release includes them.
Deployment boundary
The exact public deployment topology remains incomplete; establish hosting responsibility, data flow, availability, upgrade, service, and downtime boundaries locally.
exact submission · checked 2026-09-04 FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.
Interoperability acceptance
The FDA package describes processing of previously acquired CT DICOM studies; exact local routing, archive, and output behavior remain unverified.
exact submission · checked 2026-09-04 Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.
Clinical acceptance
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. The FDA validation scope is adult CT DICOM data with specified scanner and reconstruction conditions; do not generalize it to unsupported scanners, protocols, populations, or anatomy.
exact submission · checked 2026-09-04 Define stop-use, escalation, rollback, and revalidation triggers before production use.
Economic evaluation
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-04 No exact-product price was found in the reviewed public material; productivity or value claims require local evidence.
Lifecycle monitoring
Monitor K183268 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The FDA validation scope is adult CT DICOM data with specified scanner and reconstruction conditions; do not generalize it to unsupported scanners, protocols, populations, or anatomy.
exact submission · checked 2026-09-04 Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. cardiovascular CT analysis software limits remain submission-specific.